Black Rock Inc. Spring Works Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,619,260 shares of SWTX stock, worth $266 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,619,260
Previous 5,438,857
3.32%
Holding current value
$266 Million
Previous $268 Million
20.93%
% of portfolio
0.0%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding SWTX
# of Institutions
235Shares Held
67.2MCall Options Held
260KPut Options Held
316K-
Vanguard Group Inc Valley Forge, PA7.16MShares$339 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.46MShares$164 Million5.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.27MShares$155 Million0.01% of portfolio
-
State Street Corp Boston, MA3MShares$142 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx2.89MShares$137 Million2.02% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.96B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...